One Wall Street analyst has seen enough. Read More

The biopharma company’s second quarter was better than expected. The future looks pretty bright, too. Read More

The chipmaker has had a rough week as the global semiconductor shortage weighs on investor sentiment and analysts warn of challenges ahead. Read More

Earnings beat estimates, but the automaker’s outlook isn’t so rosy. Read More

The materials processing company reported second-quarter results and provided updates for investors. Read More

SXI earnings call for the period ending June 30, 2021. Read More

Biogen is reeling from charges that its drug doesn’t work. Read More

Torrid is going after an underserved market in plus-sized women’s clothing. Read More

The wireless module specialist reported second-quarter earnings and warned of severe supply chain disruptions. Read More

Investors are growing impatient about a planned spinoff. Read More